India pharma is crucial for global healthcare, providing affordable medicines worldwide.
India’s pharma companies excel in domestic markets and international exports.
Based on available data, here’s an overview of the top pharmaceutical companies in India
Top 25 Indian Pharmaceutical Companies by Revenue in 2024 (Domestic and Export)
| Rank | Company | Total Revenue (₹ crore) |
|---|---|---|
| 1 | Sun Pharma | 20,812.14 |
| 2 | Dr. Reddy’s Labs | 16,962.50 |
| 3 | Cipla | 15,790.60 |
| 4 | Aurobindo Pharma | 12,792.28 |
| 5 | Lupin | 11,258.83 |
| 6 | Alkem Lab | 9,054.55 |
| 7 | Zydus Life | 8,731.60 |
| 8 | Glenmark | 8,220.66 |
| 9 | Mankind Pharma | 8,127.15 |
| 10 | Torrent Pharma | 7,695.20 |
| 11 | Divis Labs | 7,625.30 |
| 12 | Ipca Labs | 5,814.62 |
| 13 | Laurus Labs | 5,773.45 |
| 14 | Abbott India | 5,348.73 |
| 15 | Alembic Pharma | 5,149.00 |
| 16 | Granules India | 3,931.20 |
| 17 | Gland | 3,616.53 |
| 18 | Piramal Pharma | 3,443.22 |
| 19 | Ajanta Pharma | 3,411.27 |
| 20 | GlaxoSmithKline | 3,216.34 |
| 21 | JB Chemicals | 2,884.16 |
| 22 | Sanofi India | 2,851.10 |
| 23 | Aarti Drugs | 2,497.97 |
| 24 | Pfizer | 2,424.76 |
| 25 | Natco Pharma | 2,351.00 |
Export Contributions
1. Export Figures:
- India’s pharmaceutical exports reached $27.9 billion in FY 2023-2024, a 9.67% increase from the previous year’s $25.4 billion. This data aligns with the Economic Survey 2024, which reports exports of $27.9 billion for FY24.
2. Major Export Destinations:
- United States accounted for over 31% of India’s pharmaceutical exports is corroborated by data indicating exports worth approximately 723 billion Indian rupees to the U.S. in FY24, making it the top destination.
3. Global Market Share:
- India supplies 20% of the global generic drug demand, over 40% of generic medicines to the U.S., and 25% to the U.K. While specific figures may vary, India’s significant contribution to the global generic drug market is well-documented.
4. Proposed U.S. Tariffs:
- Proposed U.S. tariffs on pharmaceutical imports are a potential challenge. Recent reports indicate that President Trump intends to impose a 25% or higher tariff on such imports, which could impact Indian pharma companies.
Top Pharmaceutical Exporters from India
Several Indian pharma companies have established themselves as prominent exporters, contributing significantly to pharmaceutical export revenues. Leading exporters include:
Sun Pharma is India’s largest pharmaceutical company. Sun Pharma is a prominent player in the global market for generic drugs and APIs, with operations in over 100 countries.
Dr. Reddy’s Laboratories has a strong international presence. Dr. Reddy’s exports a wide range of pharmaceutical products, particularly to the United States and Europe.
Aurobindo Pharma’s revenues are largely driven by exports, especially to the United States and Europe, making it one of India’s top pharmaceutical exporters.
Cipla has a significant international footprint, exporting pharmaceutical products to various countries across the globe.
Divi’s Labs specializes in Active Pharmaceutical Ingredients (APIs) and intermediates. It is also a leading exporter, with exports constituting a substantial portion of its revenue. In the nine months ending December 31, 2024, exports accounted for 87% of total sales revenue, with Europe and the United States contributing 72%.
These companies exemplify India’s robust pharmaceutical export capabilities, delivering quality medicines and APIs to markets worldwide.
A MedicinManAI Feature
